2 hours Edwards Lifesciences (NYSE:EW) PT Lowered to $75.00 at Royal Bank of Canada MarketBeat
Royal Bank of Canada reduced their target price on Edwards Lifesciences from $85.00 to $75.00 and set an “outperform” rating for the company in a research note on Tuesday.
Canada · Edwards Lifesciences (EW) · NYSE · Royal Bank of Canada · Science